Superworth

OptimizeRx PE ratio OPRX

Share price divided by earnings per share over the last twelve months, since 2019.

Today, Oct 23, 2026
38.1×
7-year median
32.5×
Against its 7-year history
64th
percentile: 0 is its lowest day, 100 its highest
7-year range
13.7× to 500×
Peer median
57.4×

OptimizeRx's PE ratio is 38.1× as of Oct 23, 2026: a share price of $9.15 against $0.24 of earnings per share over the last twelve months.

That is above its 7-year median of 32.5×, close to the middle of its last 7 years.

Over that time it ranged from 13.7× in May 2026 to 500× in Jul 2019.

The median for 10 credit services stocks of a similar size is 57.4×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far38.1×13.7×38.1×
2025n/m a value too high to mean anything
2024n/m a value too high to mean anything
2023n/m a value too high to mean anything
2022n/m a value too high to mean anything
2021n/m a value too high to mean anything
2020n/m a value too high to mean anything
2019322×322×500×

Against its peers

Companies in Financial - Credit Services nearest OptimizeRx's size, closest first, today.

CompanyPE ratio
OPRXOptimizeRx38.1×
DHXDHI155×
CPSSConsumer Portfolio Services10.8×
SNFCASecurity National Financial6.4×
IMXIInternational Money Express14.8×
MACIMelar Acquisition Corp. I/Cayman64.7×
POWWOutdoor82.0×
IRHOIron Horse Acquisition II67.2×
RMRegional Management6.9×
LSAKLesaka Technologies102×
RMNIRimini Street50.1×
Peer median57.4×

Where OptimizeRx ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on OptimizeRx

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.